These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27395340)

  • 1. Protective effect of recombinant soluble neprilysin against β-amyloid induced neurotoxicity.
    Oh JH; Choi S; Shin J; Park JS
    Biochem Biophys Res Commun; 2016 Sep; 477(4):614-619. PubMed ID: 27395340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin.
    Parthasarathy R; Chow KM; Derafshi Z; Fautsch MP; Hetling JR; Rodgers DW; Hersh LB; Pepperberg DR
    Exp Eye Res; 2015 Sep; 138():134-44. PubMed ID: 26142956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's disease.
    Rofo F; Metzendorf NG; Saubi C; Suominen L; Godec A; Sehlin D; Syvänen S; Hultqvist G
    Alzheimers Res Ther; 2022 Dec; 14(1):180. PubMed ID: 36471433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neprilysin protects neurons against Abeta peptide toxicity.
    El-Amouri SS; Zhu H; Yu J; Gage FH; Verma IM; Kindy MS
    Brain Res; 2007 Jun; 1152():191-200. PubMed ID: 17459354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neprilysin degrades murine Amyloid-β (Aβ) more efficiently than human Aβ: Further implication for species-specific amyloid accumulation.
    Becker M; Moore A; Naughton M; Boland B; Siems WE; Walther T
    Neurosci Lett; 2018 Nov; 686():74-79. PubMed ID: 30144539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKCε promotes HuD-mediated neprilysin mRNA stability and enhances neprilysin-induced Aβ degradation in brain neurons.
    Lim CS; Alkon DL
    PLoS One; 2014; 9(5):e97756. PubMed ID: 24848988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Messenger RNA-based therapeutics for brain diseases: An animal study for augmenting clearance of beta-amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles.
    Lin CY; Perche F; Ikegami M; Uchida S; Kataoka K; Itaka K
    J Control Release; 2016 Aug; 235():268-275. PubMed ID: 27282413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Amyloid and neprilysin computational studies identify critical residues implicated in binding specificity.
    Pope D; Madura JD; Cascio M
    J Chem Inf Model; 2014 Apr; 54(4):1157-65. PubMed ID: 24650257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between Copper, Neprilysin, and N-Truncation of β-Amyloid.
    Mital M; Bal W; Frączyk T; Drew SC
    Inorg Chem; 2018 Jun; 57(11):6193-6197. PubMed ID: 29774745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Shuttle Neprilysin reduces central Amyloid-β levels.
    Campos CR; Kemble AM; Niewoehner J; Freskgård PO; Urich E
    PLoS One; 2020; 15(3):e0229850. PubMed ID: 32155191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
    Devi L; Ohno M
    Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgens regulate neprilysin expression: role in reducing beta-amyloid levels.
    Yao M; Nguyen TV; Rosario ER; Ramsden M; Pike CJ
    J Neurochem; 2008 Jun; 105(6):2477-88. PubMed ID: 18346198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of amyloid-beta peptide and Alzheimer's disease.
    Iwata N; Higuchi M; Saido TC
    Pharmacol Ther; 2005 Nov; 108(2):129-48. PubMed ID: 16112736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan metabolites modify brain Aβ peptide degradation: A role in Alzheimer's disease?
    Maitre M; Klein C; Patte-Mensah C; Mensah-Nyagan AG
    Prog Neurobiol; 2020 Jul; 190():101800. PubMed ID: 32360535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene therapy for Alzheimer' s disease].
    Iwata N; Ozawa K; Saido TC
    Nihon Rinsho; 2005 Mar; 63(3):394-400. PubMed ID: 15773336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Tat inhibits neprilysin and elevates amyloid beta.
    Rempel HC; Pulliam L
    AIDS; 2005 Jan; 19(2):127-35. PubMed ID: 15668537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced proteolytic clearance of plasma Aβ by peripherally administered neprilysin does not result in reduced levels of brain Aβ in mice.
    Walker JR; Pacoma R; Watson J; Ou W; Alves J; Mason DE; Peters EC; Urbina HD; Welzel G; Althage A; Liu B; Tuntland T; Jacobson LH; Harris JL; Schumacher AM
    J Neurosci; 2013 Feb; 33(6):2457-64. PubMed ID: 23392674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aβ
    Leite JP; Lete MG; Fowler SB; Gimeno A; Rocha JF; Sousa SF; Webster CI; Jiménez-Bar Bero JJ; Gales L
    ACS Chem Neurosci; 2021 Oct; 12(19):3708-3718. PubMed ID: 34505762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.